These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32431594)

  • 1. The Delta-Opioid Receptor; a Target for the Treatment of Pain.
    Quirion B; Bergeron F; Blais V; Gendron L
    Front Mol Neurosci; 2020; 13():52. PubMed ID: 32431594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
    Beaudry H; Gendron L; Morón JA
    Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance.
    Zhang X; Bao L; Guan JS
    Trends Pharmacol Sci; 2006 Jun; 27(6):324-9. PubMed ID: 16678916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-dependent and abstinent mice are characterized by a broader distribution of the neurons co-expressing mu and delta opioid receptors.
    Pierre F; Ugur M; Faivre F; Doridot S; Veinante P; Massotte D
    Neuropharmacology; 2019 Jul; 152():30-41. PubMed ID: 30858104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile.
    Dietis N; Guerrini R; Calo G; Salvadori S; Rowbotham DJ; Lambert DG
    Br J Anaesth; 2009 Jul; 103(1):38-49. PubMed ID: 19474215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain Model.
    Rojewska E; Wawrzczak-Bargiela A; Szucs E; Benyhe S; Starnowska J; Mika J; Przewlocki R; Przewlocka B
    Neuroscience; 2018 Oct; 390():293-302. PubMed ID: 30176322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous targeting of multiple opioid receptor types.
    Bird MF; Lambert DG
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):98-102. PubMed ID: 25872121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists.
    Claff T; Yu J; Blais V; Patel N; Martin C; Wu L; Han GW; Holleran BJ; Van der Poorten O; White KL; Hanson MA; Sarret P; Gendron L; Cherezov V; Katritch V; Ballet S; Liu ZJ; Müller CE; Stevens RC
    Sci Adv; 2019 Nov; 5(11):eaax9115. PubMed ID: 31807708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.
    Rutten K; Schröder W; Christoph T; Koch T; Tzschentke TM
    Eur J Pharmacol; 2018 May; 827():41-48. PubMed ID: 29524385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral Delta Opioid Receptors Mediate Formoterol Anti-allodynic Effect in a Mouse Model of Neuropathic Pain.
    Ceredig RA; Pierre F; Doridot S; Alduntzin U; Hener P; Salvat E; Yalcin I; Gaveriaux-Ruff C; Barrot M; Massotte D
    Front Mol Neurosci; 2019; 12():324. PubMed ID: 32116538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5.
    Beaudry H; Mercier-Blais AA; Delaygue C; Lavoie C; Parent JL; Neugebauer W; Gendron L
    Br J Pharmacol; 2015 May; 172(10):2573-87. PubMed ID: 25598508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.
    Bird MF; Vardanyan RS; Hruby VJ; Calò G; Guerrini R; Salvadori S; Trapella C; McDonald J; Rowbotham DJ; Lambert DG
    Br J Anaesth; 2015 Apr; 114(4):646-56. PubMed ID: 25680364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of delta opioid receptors.
    Gendron L; Nagi K; Zeghal M; Giguère PM; Pineyro G
    Vitam Horm; 2019; 111():49-90. PubMed ID: 31421707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
    Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
    Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic morphine on delta opioid receptor-expressing neurons in the mouse hippocampus.
    Erbs E; Faget L; Ceredig RA; Matifas A; Vonesch JL; Kieffer BL; Massotte D
    Neuroscience; 2016 Jan; 313():46-56. PubMed ID: 26480813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics.
    Ananthan S
    AAPS J; 2006 Mar; 8(1):E118-25. PubMed ID: 16584118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of natural product regulation of opioid receptors in the treatment of human disease.
    Badal S; Turfus S; Rajnarayanan R; Wilson-Clarke C; Sandiford SL
    Pharmacol Ther; 2018 Apr; 184():51-80. PubMed ID: 29097308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Delta Opioid Receptor in Pain Control.
    Abdallah K; Gendron L
    Handb Exp Pharmacol; 2018; 247():147-177. PubMed ID: 28510066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta and kappa opioid receptors as suitable drug targets for pain.
    Vanderah TW
    Clin J Pain; 2010 Jan; 26 Suppl 10():S10-5. PubMed ID: 20026960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.